Notch-1 signaling promotes the malignant features of human breast cancer through NF-κB activation

The aberrant activation of Notch-1 signaling pathway has been proven to be associated with the development and progression of cancers. However, the specific roles and the underlying mechanisms of Notch-1 signaling pathway on the malignant behaviors of breast cancer are poorly understood. In this stu...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 9; no. 4; p. e95912
Main Authors Li, Li, Zhao, Fenglong, Lu, Juan, Li, Tingting, Yang, Hong, Wu, Chunhui, Liu, Yiyao
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 23.04.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aberrant activation of Notch-1 signaling pathway has been proven to be associated with the development and progression of cancers. However, the specific roles and the underlying mechanisms of Notch-1 signaling pathway on the malignant behaviors of breast cancer are poorly understood. In this study, using multiple cellular and molecular approaches, we demonstrated that activation of Notch-1 signaling pathway promoted the malignant behaviors of MDA-MB-231 cells such as increased cell proliferation, colony formation, adhesion, migration, and invasion, and inhibited apoptosis; whereas deactivation of this signaling pathway led to the reversal of the aforementioned malignant cellular behaviors. Furthermore, we found that activation of Notch-1 signaling pathway triggered the activation of NF-κB signaling pathway and up-regulated the expression of NF-κB target genes including MMP-2/-9, VEGF, Survivin, Bcl-xL, and Cyclin D1. These results suggest that Notch-1 signaling pathway play important roles in promoting the malignant phenotype of breast cancer, which may be mediated partly through the activation of NF-κB signaling pathway. Our results further suggest that targeting Notch-1 signaling pathway may become a newer approach to halt the progression of breast cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Correction/Retraction-3
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: LL FZ YL. Performed the experiments: LL FZ JL TL. Analyzed the data: LL FZ HY CW YL. Contributed reagents/materials/analysis tools: YL. Wrote the paper: LL YL.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0095912